Dr Reddys Labs Sa
1 products tracked · names used in filings: Dr Reddys Labs Sa
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 31 Jul 2026🇺🇸 FDA approval
FDA approves biosimilar Zimrixby (rituximab-cdxx)
Dr Reddys Labs Sa; BLA761376; Biosimilar; injection · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Zimrixby rituximab-cdxx | Approved | 2026-07-31 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.